Please use this identifier to cite or link to this item:
|Title:||Hormonal Therapy in Organ Donors.||Austin Authors:||Opdam, Helen I||Affiliation:||Department of Intensive Care, Austin Health, Heidelberg, Victoria, Australia||Issue Date:||Apr-2019||metadata.dc.date:||2019-01-24||Publication information:||Critical care clinics 2019; 35(2): 389-405||Abstract:||Optimal supportive treatment of brain dead potential organ donors maximizes donation and transplant outcomes. Brain death is associated with activation of inflammatory pathways and loss of autoregulatory brain functions that may include hypothalamic-pituitary dysfunction. As well as general supportive care, specific treatment to counter the common sequelae of brain death such as hypotension, hypothermia, and diabetes insipidus is required. In addition, the provision of specific hormonal therapy (thyroid hormone, vasopressin, and steroids) has been proposed but is controversial due to lack of high level evidence to support its efficacy.||URI:||http://ahro.austin.org.au/austinjspui/handle/1/20296||DOI:||10.1016/j.ccc.2018.11.013||PubMed URL:||30784617||Type:||Journal Article||Subjects:||Brain death
|Appears in Collections:||Journal articles|
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.